Lupin Limited has informed the Exchange regarding a press release dated August 14, 2020, titled "Lupin Presents Phase 3 Data for Solosec�� (secnidazole) Demonstrating SignificantResponse Rate in Female Patients with Trichomoniasis".
Press Release Aug 14 2020
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Lupin
- Press Release Aug 12 2020
- Press Release Aug 11 2020
- Press Release Aug 06 2020
- Press Release (Revised) Aug 06 2020
- Press Release Aug 05 2020
Later from Lupin
- Press Release Aug 25 2020
- Press Release Aug 26 2020
- Press Release Sep 02 2020
- Press Release Sep 16 2020
- Press Release Sep 22 2020
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin